Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zishen Yutai Pill for Poor Ovarian Response in IVF/ICSI-ET
ChiCTR2200062853Phase 4Not yet recruiting
- Sponsor
- Peking University Third Hospital
- Start
- Aug 2022
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in poor ovarian response (POR) comparing Zishen Yutai Pill with Placebo (2 arms). Primary endpoints: Number of high-quality embryos and High-quality embryo rate. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
Zishen Yutai Pill
03
Conditions
poor ovarian response (POR)
Beyond the preview
Go deeper on ChiCTR2200062853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062853.